XML 19 R7.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Total Shareholders' Equity
Common Shares
Treasury Shares
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Beginning balance at Jun. 30, 2024   $ 891,607 $ 72 $ (79,213) $ 353,109 $ (13,419) $ 631,058
Beginning balance ( in shares) at Jun. 30, 2024     36,107,000        
Beginning balance (in shares) at Jun. 30, 2024       7,138,000      
Increase (Decrease) in Stockholders' Equity              
Exercise of common stock options and release of restricted stock units   91 $ 1   90    
Exercise of common stock options and release of restricted stock units (in shares)     917,000        
Reissuance of treasury stock upon release of restricted stock units       19,000      
Stock Issued During Period, Value, Treasury Stock Reissued       $ 149     (149)
Withholding tax on restricted stock units   (10,355)     (10,355)    
Withholding tax on restricted stock units (in shares)     (332,000)        
Issuance of shares under ESPP (in shares)     177,000        
Stock Issued During Period, Value, Employee Stock Purchase Plan   3,421 $ 1   3,420    
Share-based compensation   21,988     21,988    
Net loss   (19,917)         (19,917)
Foreign currency translation adjustment, net of tax $ (544) (544)       (544)  
The change of equity interest in the JV Company 0            
Ending balance at Mar. 31, 2025   886,291 $ 74 $ (79,064) 368,252 (13,963) 610,992
Ending balance ( in shares) at Mar. 31, 2025     36,869,000        
Ending balance (in shares) at Mar. 31, 2025       7,119,000      
Beginning balance at Dec. 31, 2024   902,580 $ 73 $ (79,192) 370,494 (10,722) 621,927
Beginning balance ( in shares) at Dec. 31, 2024     36,367,000        
Beginning balance (in shares) at Dec. 31, 2024       7,135,000      
Increase (Decrease) in Stockholders' Equity              
Exercise of common stock options and release of restricted stock units   0 $ 1   (1)    
Exercise of common stock options and release of restricted stock units (in shares)     808,000        
Reissuance of treasury stock upon release of restricted stock units       16,000      
Stock Issued During Period, Value, Treasury Stock Reissued       $ 128     (128)
Withholding tax on restricted stock units   (9,377)     (9,377)    
Withholding tax on restricted stock units (in shares)     (306,000)        
Share-based compensation   7,136     7,136    
Net loss   (10,807)         (10,807)
Foreign currency translation adjustment, net of tax (3,241) (3,241)       (3,241)  
The change of equity interest in the JV Company 0            
Ending balance at Mar. 31, 2025   886,291 $ 74 $ (79,064) 368,252 (13,963) 610,992
Ending balance ( in shares) at Mar. 31, 2025     36,869,000        
Ending balance (in shares) at Mar. 31, 2025       7,119,000      
Beginning balance at Jun. 30, 2025 $ 822,332 822,332 $ 74 $ (79,058) 379,779 (12,390) 533,927
Beginning balance ( in shares) at Jun. 30, 2025 37,127,000   37,127,000        
Beginning balance (in shares) at Jun. 30, 2025 7,118,000     7,118,000      
Increase (Decrease) in Stockholders' Equity              
Exercise of common stock options and release of restricted stock units $ 1   $ 2   (1)    
Exercise of common stock options and release of restricted stock units (in shares)     920,000        
Reissuance of treasury stock upon release of restricted stock units     0 19,000      
Stock Issued During Period, Value, Treasury Stock Reissued       $ 148     (148)
Withholding tax on restricted stock units   (6,895) $ (1)   (6,894)    
Withholding tax on restricted stock units (in shares)     (319,000)        
Issuance of shares under ESPP (in shares)     229,000        
Stock Issued During Period, Value, Employee Stock Purchase Plan   3,590 $ 1   3,589    
Repurchase of common shares under shares repurchase program $ (18,277)     $ (18,277)      
Repurchase of common shares under shares repurchase program (in shares) (941,883)     (942,000)      
Share-based compensation   20,506     20,506    
Net loss $ (29,202) (29,202)         (29,202)
Foreign currency translation adjustment, net of tax 134 8,126       8,126  
The change of equity interest in the JV Company 7,992            
Ending balance at Mar. 31, 2026 $ 800,181 800,181 $ 76 $ (97,187) 396,979 (4,264) 504,577
Ending balance ( in shares) at Mar. 31, 2026 37,957,000   37,957,000        
Ending balance (in shares) at Mar. 31, 2026 8,041,000     8,041,000      
Beginning balance at Dec. 31, 2025   818,768 $ 75 $ (93,138) 398,072 (4,737) 518,496
Beginning balance ( in shares) at Dec. 31, 2025     37,426,000        
Beginning balance (in shares) at Dec. 31, 2025       7,844,000      
Increase (Decrease) in Stockholders' Equity              
Exercise of common stock options and release of restricted stock units $ 1   $ 2   (1)    
Exercise of common stock options and release of restricted stock units (in shares)     823,000        
Reissuance of treasury stock upon release of restricted stock units     0 17,000      
Stock Issued During Period, Value, Treasury Stock Reissued       $ 132     (132)
Withholding tax on restricted stock units   (6,194) $ (1)   (6,193)    
Withholding tax on restricted stock units (in shares)     (292,000)        
Repurchase of common shares under shares repurchase program (4,181)     $ (4,181)      
Repurchase of common shares under shares repurchase program (in shares)       (214,000)      
Share-based compensation   5,101     5,101    
Net loss (13,787) (13,787)         (13,787)
Foreign currency translation adjustment, net of tax 473 473       473  
The change of equity interest in the JV Company 0            
Ending balance at Mar. 31, 2026 $ 800,181 $ 800,181 $ 76 $ (97,187) $ 396,979 $ (4,264) $ 504,577
Ending balance ( in shares) at Mar. 31, 2026 37,957,000   37,957,000        
Ending balance (in shares) at Mar. 31, 2026 8,041,000     8,041,000